High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer

Conclusions:
The administration of higher doses of chemotherapy with stem cell support may still represent a therapeutic option (and not a recommendation) in selected BC patients. This approach should be investigated further.

Source: JNCI Monographs - June 10, 2015 Category: Cancer & Oncology Authors: Pedrazzoli, P., Martino, M., Delfanti, S., Generali, D., Rosti, G., Bregni, M., Lanza, F., on behalf of the European Group for Blood and Marrow Transplantation (EBMT), Solid Tumor Working Party Tags: Article Source Type: research